The Source • Winter 2011 • Issue 112
FDA Follows Science in Avastin Decision
by Kimberly Irish, BCA Program Manager On December 16, the Food and Drug Administration recommended that Avastin (bevacizumab) no longer be used as a treatment for metastatic breast cancer. Like many people, we are disappointed that Avastin never delivered on its promise as an effective… Read More
From the Board President: A New Look – Same Breast Cancer Action
Change is a constant practice in our lives, and some changes are bigger and therefore more apparent. In recent months at BCA, we’ve been moving through significant changes. But like everyone, we’ve risen to meet the challenge and we all remain strongly committed to our… Read More
Celebrating 20 Years of Kick-Butt Activism
By Belle Shayer, BCA founding member It’s hard to believe 20 years have passed since we sat around that kitchen table, eight women from a breast cancer support group, determined to do something besides worry. We were determined to make breast cancer a public issue,… Read More



